NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
4.280
+0.140 (3.38%)
At close: Dec 9, 2025, 4:00 PM EST
4.174
-0.106 (-2.48%)
After-hours: Dec 9, 2025, 7:49 PM EST
NuCana Market Cap
NuCana has a market cap or net worth of $17.81 million as of December 9, 2025. Its market cap has increased by 514.23% in one year.
Market Cap
17.81M
Enterprise Value
-16.07M
1-Year Change
514.23%
Ranking
Category
Stock Price
$4.28
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $17.81M, a decrease of -96.53%. That is a compound annual growth rate of -33.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 17.20M | 265.96% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.35B |
| Johnson & Johnson | 486.51B |
| AbbVie | 394.98B |
| UnitedHealth Group | 293.72B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.30B |
| Thermo Fisher Scientific | 212.85B |